Archive: Health

Showing 5051 to 5060 of 5964 entries

	Title
2002-02-18	Afghanistan opium crop threatens Europe Author (Person): Burns, Jimmy \| Hoyos, Carola Series Details: Financial Times 18.2.02, p9 Published: 18/02/2002 (Last update: 18/02/2002)
2002-02-18	Authorisation of human and veterinary medicines Author (Corporate): United Kingdom: House of Commons: European Standing Committee C Published: 18/02/2002 (Last update: 18/02/2002)
2002-02-15	Press Release: Annual Task Group Cigarettes meeting, Seville, 11-13 Febraury 2002 Author (Corporate): European Commission: European Anti-Fraud Office (OLAF) Series Details: Press Release OLAF/02/1 (15.2.02) Published: 15/02/2002 (Last update: 15/02/2002)
2002-02-15	Europe ‘addicted’ to smoking Author (Corporate): BBC Series Details: BBC News 15.2.02 Published: 15/02/2002 (Last update: 15/02/2002)
2002-02-14	Medical card to access free treatment across EU Author (Person): Osborn, Andrew Series Details: The Guardian 14.2.02, p8 Published: 14/02/2002 (Last update: 14/02/2002)
2002-02-13	Data move takes health spending nearer EU level Author (Person): Timmins, Nicholas Series Details: Financial Times 13.2.02, p4 (UK edition) Published: 13/02/2002 (Last update: 13/02/2002)
2002-02-12	Press Release: Excise duties: European Commission welcomes Council adoption of new rules on tobacco taxation Author (Corporate): European Commission: Press and Communication Service Series Details: Press Release IP/02/233 (12.2.02) Published: 12/02/2002 (Last update: 12/02/2002)
2002-02-07	Anti-drugs laws go too far, says MEP Series Details: European Voice Vol.8, No.5, 7.2.02, p2 Published: 07/02/2002 (Last update: 07/02/2002)
2002-02-07	Press Release: The fight against doping: Viviane Reding and the World Anti-Doping Agency propose an athlete’s passport Author (Corporate): European Commission: Press and Communication Service Series Details: Press Release IP/02/212 (7.2.02) Published: 07/02/2002 (Last update: 07/02/2002)
2002-02-07	Bio-Terrorism: EMEA/CPMP/4048/01 – Guidance document on use of medicinal products for treatment and prophylaxis of biological agents identified as having a major public health impact when used in case of bio-terrorist attacks Author (Corporate): European Agency for the Evaluation of Medicinal Products Published: 07/02/2002 (Last update: 07/02/2002)